Nixon Gwilt Law

JULY 23, 2024

In the recently released 2025 Medicare Physician Fee Schedule Proposed Rule (the “Proposed Rule”), the Centers for Medicare & Medicaid Services (CMS) created a new reimbursement pathway for “Digital Mental Health Treatment” (DMHT) devices and services. Whether it’s assisting you with drafting comments to the Proposed Rule ( Note!

Physicians 52

Physicians FDA Safety Management 52

Nixon Gwilt Law

JULY 23, 2024

In the recently released 2025 Medicare Physician Fee Schedule Proposed Rule (the “Proposed Rule”), the Centers for Medicare & Medicaid Services (CMS) created a new reimbursement pathway for “Digital Mental Health Treatment” (DMHT) devices and services. Whether it’s assisting you with drafting comments to the Proposed Rule ( Note!

Physicians 52

Physicians FDA Safety Management 52

European Pharmaceutical Review

DECEMBER 19, 2024

However, the road to successful implementation is fraught with concerns around data privacy, workflow integration, and acceptance by both patients and physicians, stated Sachin Gharat, Associate Project Manager, Pharma at GlobalData. In 2025, organisations must focus on addressing data integrity challenges. Internet] wh.gov.

Pharmaceutical 52

Pharmaceutical Ethics Medicine Pharma 52

PM360

NOVEMBER 12, 2024

The 2025 Healthcare CMO Summit is an exclusive invitation-only event designed to bring together Chief Medical Officers (CMOs) and innovative suppliers and solution providers. Scheduled for February 3-4, 2025 , at The Ritz-Carlton Dallas, Las Colinas , the summit will address key clinical healthcare challenges and relevant market developments.

Medical 52

Medical Healthcare Healthcare Safety 52

Nixon Gwilt Law

NOVEMBER 8, 2024

CMS issued its 2025 Medicare Physician Fee Schedule (the “2025 MPFS” or “Final Rule”) on November 1, 2024. The Final 2025 MPFS contains some modifications and clarifications to several elements of the original proposal released in July 2024 (the “Proposed Rule”), which we discussed in this earlier post.

FDA 52

FDA Physicians Management Patients 52

Pharma Marketing Network

OCTOBER 17, 2024

As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. As we move towards 2025, regulatory bodies are increasingly focusing on transparency, patient privacy, and ethical marketing practices.

Marketing 52

Marketing Healthcare Healthcare Pharma 52

pharmaphorum

DECEMBER 14, 2022

Both the physician and the patient have to be registered and the drugs can only come from a primary source through limited distribution. Tentative approval means Lumryz has satisfied all the FDA requirements for efficacy, safety, and quality standards, but it can’t be fully approved until a patent or other exclusivity expires.

Competition 116

Competition FDA Pharmaceutical Marketing 116